Please log in to determine if you are eligible to purchase PT Programs.
GYNECOLOGICAL CYTOLOGY OUTCOMES - QT5
QT5
The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results is a significant part of the cytopathology laboratory’s quality assurance program. By monitoring this correlation, the laboratory can identify and address potential problems requiring improvement, thereby ensuring better patient results. This Q-TRACKS study helps laboratories meet CAP Laboratory Accreditation Program Cytopathology Checklist statements CYP.01900, CYP.07543, and CYP.07600 on cytologic/histologic correlation, and The Joint Commission Standard QSA. 08.06.03: The cytology laboratory has a process to correlate cytologic interpretations with the corresponding histologic finding.
Objective
Quantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.
Data Collection
On a monthly basis, participants will record the number of true-positive, false-positive, and false-negative cytology-biopsy correlations. The false-negative correlations will be classified into four error categories: screening errors, interpretive errors, screening and interpretive errors, and adequacy determination errors. Participants will also record the biopsy diagnoses for Pap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or atypical glandular cells (AGC). This monitor includes cervical biopsy specimens submitted to the laboratory that have a corresponding satisfactory or satisfactory but limited Pap test within three months of the biopsy.
Performance Indicators
Predictive value of positive cytology (%)
Sensitivity (%)
Screening/interpretation sensitivity (%)
Sampling sensitivity (%)
Percent positive for ASC-US interpretations
Percent positive for ASC-H interpretations
Percent positive for AGC interpretations
Shipping Schedule
Shipment A: December 5, 2022
Shipment B: March 13, 2023
Shipment C: June 12, 2023
Shipment D: September 11, 2023
Additional Information
Participants in this program receive:
User Guide
Templates and instructions for data collection
Quarterly reports that include fingerprint clusters, customer-defined groups, and all institution comparisons
Peer directory
Quality Management Tools activities meet the American Board of Pathology MOC Part IV Practice Performance Assessment requirements.
Satisfaction with Outpatient Specimen Collection (QT7)
✓
✓
✓
✓
Stat Test Turnaround Time Outliers (QT8)
✓
✓
✓
✓
✓
✓
Critical Values Reporting (QT10)
✓
✓
✓
✓
✓
Troponin Turnaround Times (QT15)
✓
✓
✓
✓
✓
✓
✓
✓
Corrected Results (QT16)
✓
✓
✓
✓
✓
✓
✓
✓
Outpatient Order Entry Errors (QT17)
✓
✓
✓
✓
✓
✓
✓
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes benchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requires accredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor, assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).
Help